{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:51:54Z","timestamp":1790070714034,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust"},{"name":"UCL Institute of Ophthalmology, Moorfields Special Trustees, the Helen Hamlyn Trust (in memory of Paul Hamlyn), Medical Research Council, Fight for Sight and the Michael and Ilse Katz foundation"},{"name":"UCL Overseas Research Student Fund"},{"name":"UCL Comprehensive Biomedical Research Centre"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijpharm.2017.02.047","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T19:33:57Z","timestamp":1487705637000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Sustained release ophthalmic dexamethasone: In vitro in vivo correlations derived from the PK-Eye"],"prefix":"10.1016","volume":"522","author":[{"given":"Sahar","family":"Awwad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng T.","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Brocchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala M.","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.02.047_bib0005","unstructured":"Package insert prescribing information. Pegaptanib sodium Inject NDA-21-756\/S-018 Ref ID 3026883. 2011."},{"issue":"10","key":"10.1016\/j.ijpharm.2017.02.047_bib0010","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/jps.24480","article-title":"PK-Eye. The A novel in vitro ocular flow model for use in preclinical drug development","volume":"104","author":"Awwad","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.02.047_bib0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2009.03.012","article-title":"Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone","volume":"89","author":"Barcia","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0020","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/0091270011412961","article-title":"Population pharmacokinetics of pegaptanib in patients with neovascular. Age-related macular degeneration","volume":"52","author":"Basile","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.02.047_bib0025","first-page":"574","article-title":"Integrating disease progression models, non-clinical pharmacokinetic data and treatment response endpoints to optimize intravitreal dosing regimens","volume":"52","author":"Basile","year":"2014","journal-title":"Int. J. Clin. Pharmacol Ther."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.02.047_bib0030","first-page":"681","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Am. Acad. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ijpharm.2017.02.047_bib0035","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jps.2600650329","article-title":"Aqueous solubility of 14C-triamcinolone acetonide","volume":"65","author":"Behl","year":"1976","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.02.047_bib0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.actbio.2007.09.011","article-title":"Novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery","volume":"4","author":"Blaker","year":"2008","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0045","first-page":"391","article-title":"The flow of aqueous humor in the human eye","volume":"80","author":"Brubaker","year":"1982","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/164692","article-title":"Sustained-release corticosteroid options","volume":"2014","author":"Cabrera","year":"2014","journal-title":"J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.ijpharm.2017.02.047_bib0055","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1167\/iovs.10-6387","article-title":"Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.02.047_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2013.01.007","article-title":"Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation","volume":"167","author":"Chennamaneni","year":"2013","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijpharm.2017.02.047_bib0065","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/jps.21987","article-title":"A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases","volume":"99","author":"Choonara","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0070","first-page":"126463","article-title":"Intravitreal devices for the treatment of vitreous inflammation","volume":"2012","author":"Christoforidis","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2014.04.049","article-title":"Single compartment drug delivery","volume":"190","author":"Cima","year":"2014","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijpharm.2017.02.047_bib0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.survophthal.2007.12.005","article-title":"Intravitreal steroids for macular edema: the past, the present, and the future","volume":"53","author":"Cunningham","year":"2008","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data","volume":"137","author":"del Amo","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.bioeng.6.040803.140055","article-title":"Ocular biomechanics and biotransport","volume":"6","author":"Ethier","year":"2004","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2017.02.047_bib0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2009.08.003","article-title":"Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems","volume":"382","author":"Fadda","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.02.047_bib0100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/ten.tec.2009.0599","article-title":"Anti-tumor necrosis factor-alpha-loaded microspheres as a prospective novel treatment for Crohn\u2019s disease fistulae","volume":"16","author":"Foong","year":"2010","journal-title":"Tissue Eng."},{"issue":"11","key":"10.1016\/j.ijpharm.2017.02.047_bib0105","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00417-005-1182-1","article-title":"Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis","volume":"243","author":"Gan","year":"2005","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.02.047_bib0110","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.msec.2012.12.098","article-title":"Preparation of porous microsphere-scaffolds by electrohydrodynamic forming and thermally induced phase separation","volume":"33","author":"Ghanbar","year":"2013","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.ijpharm.2017.02.047_bib0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11095-012-0847-9","article-title":"Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment","volume":"30","author":"Haghjou","year":"2013","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ijpharm.2017.02.047_bib0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2007.06.004","article-title":"Triamcinolone acetonide in ocular therapeutics","volume":"52","author":"Jermak","year":"2007","journal-title":"Surv. Ophthalmol."},{"issue":"8","key":"10.1016\/j.ijpharm.2017.02.047_bib0125","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1167\/iovs.10-6233","article-title":"Sclera-choroid-RPE transport of eight \u03b2-blockers in human, bovine, porcine, rabbit, and rat models","volume":"52","author":"Kadam","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0130","first-page":"6407","article-title":"Artificial vitreous humor for in vitro experiments","author":"Kummer","year":"2007","journal-title":"Conf. Proc. Int. Conf. IEEE Eng. Med. Biol. Soc."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1992.01080140115038","article-title":"Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection","volume":"110","author":"Kwak","year":"1992","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ijpharm.2017.02.047_bib0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.preteyeres.2010.04.003","article-title":"Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics","volume":"29","author":"Laude","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"10.1016\/j.ijpharm.2017.02.047_bib0145","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-010-0159-x","article-title":"Biodegradable implants for sustained drug release in the eye","volume":"27","author":"Lee","year":"2010","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2017.02.047_bib0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","article-title":"Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes","volume":"47","author":"Loch","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jcis.2016.01.021","article-title":"Electrospray synthesis and properties of hierarchically structured PLGA TIPS microspheres for use as controlled release technologies","volume":"467","author":"Malik","year":"2016","journal-title":"J. Colloid Interface Sci."},{"issue":"4","key":"10.1016\/j.ijpharm.2017.02.047_bib0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/108076801753162807","article-title":"Review practical issues in intravitreal drug delivery","volume":"17","author":"Maurice","year":"2001","journal-title":"J. Ocul. Pharmacol."},{"issue":"9","key":"10.1016\/j.ijpharm.2017.02.047_bib0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/jop.2014.0010","article-title":"Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema","volume":"30","author":"Medeiros","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-fluid-120710-101058","article-title":"Fluid mechanics of the eye","volume":"44","author":"Siggers","year":"2012","journal-title":"Annu. Rev. Fluid Mech."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0175","first-page":"59","article-title":"Artificial vitreous replacements","volume":"13","author":"Soman","year":"2003","journal-title":"Biomed. Mater. Eng."},{"issue":"10","key":"10.1016\/j.ijpharm.2017.02.047_bib0180","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/17425247.2014.927864","article-title":"Intravitreal drug delivery in retinal disease: are we out of our depth?","volume":"11","author":"Thakur","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"5\u20136","key":"10.1016\/j.ijpharm.2017.02.047_bib0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.ijpharm.2017.02.047_bib0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9394(98)00436-X","article-title":"Aqueous humor dynamics in the aging human eye","volume":"127","author":"Toris","year":"1999","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ijpharm.2017.02.047_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/jop.2012.0210","article-title":"Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist intended for the treatment of vascular complications of the eye","volume":"29","author":"Yandrapu","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2017.02.047_bib0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJN.S6428","article-title":"Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits","volume":"4","author":"Zhang","year":"2009","journal-title":"Int. J. Nanomed."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:53:49Z","timestamp":1536022429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317301370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0378517317301370"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.047","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained release ophthalmic dexamethasone: In vitro in vivo correlations derived from the PK-Eye","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}